Donepezil

From Proteopedia

proteopedia linkproteopedia link

spinqualitylabelsall models Donepezil, also known as Aricept Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image

Better Known as: Aricept

• Marketed By: Eisai & Pfizer
  
• Major Indication: Alzheimer's Disease
  
• Drug Class: Acteylcholinesterase Inhibitor
• Date of FDA Approval (Withdrawn): 1996 (2008)
  
• 2006 Sales: $800 Million
• Why You Should Care: One of the most effective treatments for teh symptoms of Alzheimer's Disease, although no definitive proof exists as to whether to alters the progression of the disease.
• The following is a list of Pharmacokinetic Parameters. See: Pharmaceutical Drugs for more information

Mechanism of Action

Pharmacokinetics

Aceylcholinesterase Inhibitor Pharmacokinetics
Parameter	Aricept
Tmax (hr)
Cmax (ng/ml)
Bioavailability (%)
Protein Binding (%)
T1/2 (hr)
AUC (ng/ml/hr)
IC50 (nM)
Equivalent LDL Reduction Dosage (mg)
Metabolism

References